Group 1 - Enwei Pharmaceutical's stock price increased by 5.16% on January 8, reaching 28.96 CNY per share, with a total market capitalization of 2.98 billion CNY [1] - The company has experienced a continuous rise in stock price for four consecutive days, with a cumulative increase of 5.8% during this period [1] - Enwei Pharmaceutical specializes in the research, production, and sales of traditional Chinese medicine and chemical drugs, focusing on gynecological products, pediatric medications, and respiratory system drugs [1] Group 2 - According to data, a fund managed by China Merchants Asset Management holds a significant position in Enwei Pharmaceutical, with 7,900 shares, accounting for 1.14% of the fund's net value [2] - The fund, China Merchants Asset Management Zhida Quantitative Stock Mixed Fund A, has generated a floating profit of approximately 11,200 CNY today and 11,900 CNY during the four-day rising period [2] - The fund has a total asset size of 20.91 million CNY and has achieved a year-to-date return of 3.7% [2]
恩威医药股价涨5.16%，招商资管旗下1只基金重仓，持有7900股浮盈赚取1.12万元